588 Article Views
Publication Date: 31 Oct 2011
Journal: Clinical Medicine Insights: Women's Health
doi: 10.4137/CMWH.S6715
Polycystic ovary syndrome is an endocrine disorder characterized by insulin resistance, hyperandrogenemia, obesity, and inflammation, and is the most common cause of infertility. Women with PCOS are at higher risk than non-PCOS women for diabetes, cardiovascular disease, endometrial cancer, and psychiatric disorders. Because many abnormalities present in PCOS and symptoms vary considerably among PCOS women, treatment is guided by presentation and does not consist of simply one modality. Often, however, one type of medication can ameliorate more than one abnormality in PCOS. This review summarizes current research on several treatment modalities for PCOS, including drugs that are fairly well-established as efficacious and other agents that may prove efficacious in the future, with particular emphasis on the benefits and barriers of lifestyle change.
Discussion
No comments yet...Be the first to comment.
My laboratory has published several papers in Cell Communication Insights. In each case, reviewer comments were returned promptly; the suggested revisions were both fair and quite helpful, reflecting positively on the quality of the review. Once accepted, the editorial office provided clear and frequent updates on the progress of our manuscripts through each step of the publication process. When necessary, I had prompt email responses to my questions and the figure quality was exceptional. Keep up the outstanding work.Dr Paul J. Higgins (Director, Center for Cell Biology & Cancer Research, Albany Medical College, Albany, New York, USA) What Your Colleagues Say
Copyright © 2012 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)
FacebookGoogle+Twitter
PinterestTumblrYouTube